bostonglobe.com/2024/09/03/met… This Boston Globe article chronicles the surreal tale of the looting of an ailing hospital system by its own CEO. The story begins in February of 2022 when the CEO of Steward Health Care, Dr. Ralph de la Torre, was making a $ 10 Million donation for a

De-escalation to Ticagrelor Monotherapy Beneficial in Ischemic Events and Bleeding vs 12 months of DAPT Written by John Vitarello MD! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/de-escalation-… C. Michael Gibson MD

AZALEA-TIMI 71 Sub-study: Periprocedural Bleeding Risk Very Low and Similar With Long-acting Factor XI Inhibitor Abelacimab vs Rivaroxaban Written by Adam Alhassan MD, MPH! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/azalea-timi-71… C. Michael Gibson MD

Bailout GP IIb/IIIa inhibition in AMI with Angiographic MVO failed to reduce infarct size but decreased CMR-derived MVO: REVERSE FLOW Written by Dami Aladesanmi! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/bailout-gp-iib… C. Michael Gibson MD

Plozasiran Lowered Triglyceride Levels and Pancreatitis in Persistent Chylomicronemia: PALISADE Written by Dami Aladesanmi! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/plozasiran-low… C. Michael Gibson MD

REC-CAGEFREE I: Drug Coated Balloon Fails To Achieve Non-Inferiority vs DES For De Novo Coronary Lesions Written by Inbar McCarthy MD! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/rec-cagefree-i… C. Michael Gibson MD

It’s during that awkward silence that the light gets in #cmgsays Fahad Waqar, MD

💥 LIVE TOMORROW! Current anticoagulants are effective, but the safety profile is a challenge. Factor XI could change the game in thrombosis prevention, key to safer, broader use. C. Michael Gibson MD + Dr Ruff present the latest evidence! 💥 Save the Date: ms.spr.ly/6015l0DzZ

The frontostriatal salience network is expanded nearly twofold in the cortex of most individuals with depression. This effect was replicable in several samples. nature.com/articles/s4158…

Here’s the last #ESCSnacks episode form #ESCCongress brought to you by C. Michael Gibson MD discussing the OCEANIC AF trial presented during the congress. Hosted by Novi Tham We take this opportunity to thank our community for their support and involvement in the ESC Social Media

I discuss an exploratory analysis from AEGIS 2 showing that among patients with an LDL > 100 mg/dl, an infusion of Apo-A1 (CSL 112) reduces death and MI by 36% touchcardio.com/?p=71037

We are going live at 2:30 PM Eastern!

European Society of Cardiology C. Michael Gibson MD Novi Tham Very interesting last #ESCSnack, thanks for sharing these insights. Madrid is waiting with #ESCTapas and sangría, of course 😊 🇪🇦 #ESCCongress2025

Dr. Gibson and Dr. Mehra discuss the MOMENTUM-3 Trial that led to FDA approval to drop Aspirin in HeartMate 3 patients.

ECLS-SHOCK: At One Year, ECMO Does Not Reduce Mortality in Acute MI-Related Cardiogenic Shock Written by Leah Kosyakovsky! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/ecls-shock-at-… C. Michael Gibson MD

Pre-Hospital Pulse-Dose Glucocorticoid Did not Reduce Infarct Size in STEMI: PULSE-MI Written by Alberto Castro! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/pre-hospital-p… C. Michael Gibson MD

Improved Accuracy of HF Diagnosis with HFDetect-AI Written by Alberto Castro! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/improved-accur… C. Michael Gibson MD

Apolipoprotein A-I infusions Lowers Risk of Recurrent CV Events in Patients With Baseline LDL-C ≥100 mg/dL Written by Christina Lalani! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/apolipoprotein… C. Michael Gibson MD

ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction Written by Christina Lalani! Summary, analysis and more #ESCCongress coverage below! cardiologynownews.org/apoa-i-infusio… C. Michael Gibson MD